no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine
|
Babiuk, Shawn |
|
2011 |
29 |
17 |
p. 3118-3123 6 p. |
article |
2 |
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults
|
Talaat, Kawsar R. |
|
2011 |
29 |
17 |
p. 3144-3148 5 p. |
article |
3 |
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate
|
Lousada-Dietrich, Susana |
|
2011 |
29 |
17 |
p. 3284-3292 9 p. |
article |
4 |
Bioprocess optimization for cell culture based influenza vaccine production
|
Aggarwal, Kunal |
|
2011 |
29 |
17 |
p. 3320-3328 9 p. |
article |
5 |
Canadian paediatricians’ opinions on rotavirus vaccination
|
Dubé, E. |
|
2011 |
29 |
17 |
p. 3177-3182 6 p. |
article |
6 |
Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2
|
Kim, D. |
|
2011 |
29 |
17 |
p. 3206-3212 7 p. |
article |
7 |
Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus
|
Schanen, Brian C. |
|
2011 |
29 |
17 |
p. 3299-3309 11 p. |
article |
8 |
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
|
Rehm, Kristina E. |
|
2011 |
29 |
17 |
p. 3276-3283 8 p. |
article |
9 |
Development and immunogenicity of recombinant GapA+ Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6
|
Shil, Pollob K. |
|
2011 |
29 |
17 |
p. 3197-3205 9 p. |
article |
10 |
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults
|
Crum-Cianflone, Nancy F. |
|
2011 |
29 |
17 |
p. 3183-3191 9 p. |
article |
11 |
Editorial Board
|
|
|
2011 |
29 |
17 |
p. CO2- 1 p. |
article |
12 |
Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal
|
Shuaibu, M.N. |
|
2011 |
29 |
17 |
p. 3239-3247 9 p. |
article |
13 |
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines
|
Libbey, Jane E. |
|
2011 |
29 |
17 |
p. 3356-3362 7 p. |
article |
14 |
Human papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010
|
Bednarczyk, Robert A. |
|
2011 |
29 |
17 |
p. 3138-3143 6 p. |
article |
15 |
IABS international scientific workshop—Mode of Action of Adjuvants: Implications for vaccine safety and design, April 29–30, 2010, Bethesda, MD, USA
|
Seemann, Séverine |
|
2011 |
29 |
17 |
p. 3340- 1 p. |
article |
16 |
Identification and characterization of protective epitope of Trichinella spiralis paramyosin
|
Wei, Junfei |
|
2011 |
29 |
17 |
p. 3162-3168 7 p. |
article |
17 |
Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42
|
Axelsen, Trine Veje |
|
2011 |
29 |
17 |
p. 3260-3269 10 p. |
article |
18 |
Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III
|
Lancaster, Lorna |
|
2011 |
29 |
17 |
p. 3213-3221 9 p. |
article |
19 |
Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
|
Rusnak, Janice M. |
|
2011 |
29 |
17 |
p. 3222-3229 8 p. |
article |
20 |
Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets
|
Ellebedy, A.H. |
|
2011 |
29 |
17 |
p. 3335-3339 5 p. |
article |
21 |
Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4+ T cell responses
|
Moorman, Jonathan P. |
|
2011 |
29 |
17 |
p. 3169-3176 8 p. |
article |
22 |
Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge
|
Rajasekaran, Parthiban |
|
2011 |
29 |
17 |
p. 3106-3110 5 p. |
article |
23 |
Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques
|
Marthas, Marta L. |
|
2011 |
29 |
17 |
p. 3124-3137 14 p. |
article |
24 |
Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris
|
Liu, Pei-Feng |
|
2011 |
29 |
17 |
p. 3230-3238 9 p. |
article |
25 |
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds
|
Murata, Haruhiko |
|
2011 |
29 |
17 |
p. 3155-3161 7 p. |
article |
26 |
Population diversity in batches of the varicella Oka vaccine
|
Kanda, R.K. |
|
2011 |
29 |
17 |
p. 3293-3298 6 p. |
article |
27 |
Predictors of hepatitis A vaccination among young children in the United States
|
Byrd, Kathy K. |
|
2011 |
29 |
17 |
p. 3254-3259 6 p. |
article |
28 |
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda
|
Tate, Jacqueline E. |
|
2011 |
29 |
17 |
p. 3329-3334 6 p. |
article |
29 |
Public engagement on ethical principles in allocating scarce resources during an influenza pandemic
|
Bailey, Tracey M. |
|
2011 |
29 |
17 |
p. 3111-3117 7 p. |
article |
30 |
Response to hepatitis B vaccine differs by birthweight among neonates
|
Çekmez, Ferhat |
|
2011 |
29 |
17 |
p. 3096-3097 2 p. |
article |
31 |
Salmonella Enteritidis with double deletion in phoPfliC—A potential live Salmonella vaccine candidate with novel characteristics for use in chickens
|
Methner, Ulrich |
|
2011 |
29 |
17 |
p. 3248-3253 6 p. |
article |
32 |
Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995–2009
|
Ho, Pak-Leung |
|
2011 |
29 |
17 |
p. 3270-3275 6 p. |
article |
33 |
Sustaining GAVI-supported vaccine introductions in resource-poor countries
|
Zuber, Patrick L.F. |
|
2011 |
29 |
17 |
p. 3149-3154 6 p. |
article |
34 |
Synthesis and immunogenicity of a Helicobacter pylori lipopolysaccharide-based conjugate
|
Monteiro, Mario A. |
|
2011 |
29 |
17 |
p. 3098-3102 5 p. |
article |
35 |
The first case of Nocardia transvalensis infection in varicella in a previously immunocompetent child
|
Bozzola, Elena |
|
2011 |
29 |
17 |
p. 3103-3105 3 p. |
article |
36 |
The school nurse, the school and HPV vaccination: A qualitative study of factors affecting HPV vaccine uptake
|
Brabin, Loretta |
|
2011 |
29 |
17 |
p. 3192-3196 5 p. |
article |
37 |
TLR-based immune adjuvants
|
Steinhagen, Folkert |
|
2011 |
29 |
17 |
p. 3341-3355 15 p. |
article |
38 |
Towards validated assays for key immunological outcomes in malaria vaccine development
|
Cavanagh, David R. |
|
2011 |
29 |
17 |
p. 3093-3095 3 p. |
article |
39 |
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia
|
Brocca-Cofano, Egidio |
|
2011 |
29 |
17 |
p. 3310-3319 10 p. |
article |